{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:46:54Z","timestamp":1791233214866,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jnutbio.2022.109071","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T12:03:21Z","timestamp":1653653001000},"page":"109071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Multidrug resistance-associated protein 2 (MRP2) is an efflux transporter of EGCG and its metabolites in the human small intestine"],"prefix":"10.1016","volume":"107","author":[{"given":"Takuya","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-5160","authenticated-orcid":false,"given":"Junichi","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2022.109071_bib0001","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C8FO01997E","article-title":"The effects of polyphenols and other bioactives on human health","volume":"10","author":"Fraga","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.fct.2017.10.023","article-title":"Current evidence on the effect of dietary polyphenols intake on chronic diseases","volume":"110","author":"Costa","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0003","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.3390\/nu5103779","article-title":"Polyphenols: benefits to the cardiovascular system in health and in aging","volume":"5","author":"Khurana","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0004","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/ajcn\/80.6.1558","article-title":"Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement","volume":"80","author":"Henning","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0005","first-page":"1045","article-title":"Absorption, distribution, elimination of tea polyphenols in rats","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0006","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1271\/bbb.61.1981","article-title":"Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma","volume":"61","author":"Nakagawa","year":"1997","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fphar.2017.00325","article-title":"Identification of epigallocatechin-3-gallate as an inhibitor of phosphoglycerate mutase 1","volume":"8","author":"Li","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0008","first-page":"105","article-title":"Pharmacokinetic and chemoprevention studies on tea in humans","volume":"64","author":"Chow","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/bdd.735","article-title":"The membrane transport of flavonoids from crossostephium chinense across the Caco-2 monolayer","volume":"32","author":"Wang","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejps.2003.10.010","article-title":"Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption","volume":"21","author":"Steffansen","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jnutbio.2022.109071_bib0011","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0169-409X(01)00180-6","article-title":"Chitosan and its derivatives as intestinal absorption enhancers","volume":"50","author":"Thanou","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0773.2002.t01-1-910403.x","article-title":"The involvement of P-glycoprotein in berberine absorption","volume":"91","author":"Pan","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14712\/18059694.2016.9","article-title":"Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver","volume":"54","author":"Smetanova","year":"2011","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0014","unstructured":"FDA. Food and Drug Administration GfI. Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. 2000."},{"key":"10.1016\/j.jnutbio.2022.109071_bib0015","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/jphp.13111","article-title":"Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines","volume":"71","author":"Jarc","year":"2019","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03602532.2017.1293682","article-title":"Glucuronidation: driving factors and their impact on glucuronide disposition","volume":"49","author":"Yang","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0017","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/nure.12114","article-title":"Dietary factors affecting polyphenol bioavailability","volume":"72","author":"Bohn","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0018","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0019","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults - results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.phrs.2011.03.001","article-title":"Cancer prevention by tea: evidence from laboratory studies","volume":"64","author":"Yang","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrc2641","article-title":"Cancer prevention by tea: animal studies, molecular mechanisms and human relevance","volume":"9","author":"Yang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.physbeh.2016.01.044","article-title":"Nutraceuticals for body-weight management: the role of green tea catechins","volume":"162","author":"Janssens","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0023","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ejcn.2014.143","article-title":"The anti-obesity effects of green tea in human intervention and basic molecular studies","volume":"68","author":"Huang","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0024","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3945\/ajcn.116.144972","article-title":"Tea catechin and caffeine activate brown adipose tissue and increase cold-induced thermogenic capacity in humans","volume":"105","author":"Yoneshiro","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2015.03.158","article-title":"Green tea catechins enhance norepinephrine-induced lipolysis via a protein kinase A-dependent pathway in adipocytes","volume":"461","author":"Chen","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0026","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","article-title":"Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate","volume":"66","author":"Khan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0027","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2174\/138920006778520552","article-title":"Metabolism of green tea catechins: an overview","volume":"7","author":"Feng","year":"2006","journal-title":"Curr Drug Metab"},{"issue":"Suppl 1","key":"10.1016\/j.jnutbio.2022.109071_bib0028","first-page":"S44","article-title":"Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans","volume":"53","author":"Stalmach","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0029","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1017\/S0007114512004370","article-title":"Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis)","volume":"109","author":"Fung","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0030","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1038\/s41598-019-47214-4","article-title":"Identification of the catechin uptake transporter responsible for intestinal absorption of epigallocatechin gallate in mice","volume":"9","author":"Ishii","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0031","first-page":"12","article-title":"In-depth characterization of epiintestinal microtissue as a model for intestinal drug absorption and metabolism in human","author":"Cui","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0032","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0090-9556(25)07382-9","article-title":"Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells","volume":"24","author":"Prueksaritanont","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0033","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0034","doi-asserted-by":"crossref","first-page":"e29647","DOI":"10.1371\/journal.pone.0029647","article-title":"Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in Caco-2 cells","volume":"7","author":"Teng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/dmd.31.4.452","article-title":"Glucuronides of tea catechins: enzymology of biosynthesis and biological activities","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0036","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/dmd.31.5.572","article-title":"Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0037","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/mol.51.5.741","article-title":"Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3","volume":"51","author":"Schmiedlin-Ren","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.08.020","article-title":"Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model","volume":"287","author":"Zhang","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0039","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s11095-014-1305-7","article-title":"Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1","volume":"31","author":"Shirasaka","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0041","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2003.07.003","article-title":"The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability","volume":"21","author":"Chan","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0042","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/mol.108.052019","article-title":"Intestinal breast cancer resistance protein (BCRP)\/Bcrp1 and multidrug resistance protein 3 (MRP3)\/Mrp3 are involved in the pharmacokinetics of resveratrol","volume":"75","author":"van de Wetering","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0043","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.110.036640","article-title":"Interactions of green tea catechins with organic anion-transporting polypeptides","volume":"39","author":"Roth","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0044","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2003.09.007","article-title":"Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites","volume":"310","author":"Hong","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejps.2012.02.016","article-title":"Impact of probe compound in MRP2 vesicular transport assays","volume":"46","author":"Kidron","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0046","first-page":"621","article-title":"Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models","volume":"14","author":"Oh","year":"2019","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.jnutbio.2022.109071_bib0047","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s11095-005-4584-1","article-title":"Pharmacokinetics and modeling of quercetin and metabolites","volume":"22","author":"Chen","year":"2005","journal-title":"Pharm Res"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286322001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286322001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:38:35Z","timestamp":1760629115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286322001425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"alternative-id":["S0955286322001425"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109071","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidrug resistance-associated protein 2 (MRP2) is an efflux transporter of EGCG and its metabolites in the human small intestine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2022.109071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109071"}}